Location History:
- Zeist, NL (2015 - 2021)
- Utrecht, NL (2020 - 2023)
Company Filing History:
6 out of 24 
1 out of 51 
Years Active: 2015-2023
Title: Hendrik Peter Haagsman: Innovating Antimicrobial Solutions
Introduction
Hendrik Peter Haagsman is a prominent inventor based in Utrecht, Netherlands, known for his significant contributions to the field of antimicrobial peptides. With a total of six patents to his name, Haagsman has pioneered innovative solutions that hold potential for applications in medicine and vaccine development.
Latest Patents
One of Haagsman's latest innovations is related to CATH2 derivatives. His invention presents new derivatives of CATH2 or CMAP27, both recognized as cathelicidins. These derivatives include N-terminally truncated peptides, cyclic peptides, D-amino acid variants, as well as inverso and retroinverso CATH2 derivatives. The potential applications of these derivatives range from anti-infectives to vaccine development, notably for in ovo applications. Additionally, the derivatives possess newly described immunoactivating functions that are particularly beneficial for prophylactic treatments. Another significant invention focuses on antimicrobial peptides based on CMAP27, which exhibit improved antimicrobial activity while maintaining low haemolytic activity compared to the wild-type CMAP27 peptide. These derivatives are considered valuable for antibiotic therapy and bacteriocidal compositions, with the added capability of serving as adjuvants.
Career Highlights
Haagsman has worked with notable institutions such as Universiteit Utrecht Holding B.V. and UMC Utrecht Holding B.V. through which he has further advanced his research and development efforts.
Collaborations
Throughout his career, Haagsman has collaborated with several professionals in his field, including Albert Van Dijk and Edwin Johannes Adrianus Veldhuizen. These partnerships have facilitated the exchange of knowledge and innovation, enhancing the impact of his work.
Conclusion
Hendrik Peter Haagsman’s commitment to innovation in the realm of antimicrobial peptides places him at the forefront of scientific advancement. His patents reflect a thoughtful approach to addressing medical challenges, making significant strides towards effective therapies and vaccine development. With a focus on improving health outcomes, Haagsman's contributions will undoubtedly continue to influence the field for years to come.